Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Harold A. Robertson"'
Autor:
Laura J. Pimer, Ronald A. Leslie, Gosia Phillips, Aaron J. Newman, Benjamin Rusak, Tyler M. Rolheiser, Kerrie Schoffer, M. Naeem Khan, J. Roger McKelvey, Harold A. Robertson, Kimberley P. Good
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 8, Iss , Pp 100182- (2023)
Introduction: Parkinson’s disease (PD) is typically diagnosed when motor symptoms first occur. However, PD-related non-motor symptoms may appear several years before diagnosis. REM sleep behaviour disorder (RBD) and olfactory deficits (hyposmia) ar
Externí odkaz:
https://doaj.org/article/b8311010bc304b3c87d8ae55e48ee95d
Publikováno v:
BioTechniques, Vol 26, Iss 6, Pp 1046-1050 (1999)
Externí odkaz:
https://doaj.org/article/f887dbb489e5493ea61d14f58417ec05
Autor:
John D. Fisk, Harold A. Robertson, Gail A. Eskes, Sophie A Stewart, J. Roger McKelvey, Tyler Rolheiser, Ron A Leslie, M. Naeem Khan, Benjamin Rusak, Kerrie Schoffer, Laura Pimer, Kimberley P. Good
Publikováno v:
Clinical EEG and Neuroscience. 54:91-97
Parkinson's disease (PD) is a neurodegenerative disorder that is typified by motor signs and symptoms but can also lead to significant cognitive impairment and dementia Parkinson's Disease Dementia (PDD). While dementia is considered a nonmotor featu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9370dbb09bf2c7dccbac5ff0e62d861d
https://doi.org/10.1177/15500594211058263
https://doi.org/10.1177/15500594211058263
Autor:
Jackalina M Van Kampen, David C Baranowski, Harold A Robertson, Christopher A Shaw, Denis G Kay
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0139694 (2015)
The development of effective neuroprotective therapies for Parkinson's disease (PD) has been severely hindered by the notable lack of an appropriate animal model for preclinical screening. Indeed, most models currently available are either acute in n
Externí odkaz:
https://doaj.org/article/821ee5f4b4ef41bf8135975bf5efafb9
Publikováno v:
The EPMA Journal
Parkinson’s disease (PD) is a neurodegenerative disorder, classically considered a movement disorder. A great deal is known about the anatomical connections and neuropathology and pharmacological changes of PD, as they relate to the loss of dopamin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73997d7078458b1d73b2373c45e85eb5
http://europepmc.org/articles/PMC5613678
http://europepmc.org/articles/PMC5613678
Autor:
Namrata Joshi, M. N. Khan, M. Armstrong, Harold A. Robertson, Benjamin Rusak, G. Phillips, J. R. McKelvey, Kimberly P. Good, John D. Fisk, K. Schoffer, Tyler Rolheiser, R. A. Leslie
Publikováno v:
Journal of Neurology. 264:1497-1505
Parkinson's disease (PD) is a progressive neurological disorder characterized by motor symptoms as well as severe deficits in olfactory function and microstructural changes in olfactory brain regions. Because of the evidence of asymmetric neuropathol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::307b59bcda39b7e75a09f28f5f0d4678
https://doi.org/10.1007/s00415-017-8555-3
https://doi.org/10.1007/s00415-017-8555-3
Publikováno v:
Cell Reports, Vol 7, Iss 6, Pp 1755-1761 (2014)
SummaryTo determine the long-term health and function of transplanted dopamine neurons in Parkinson’s disease (PD) patients, the expression of dopamine transporters (DATs) and mitochondrial morphology were examined in human fetal midbrain cellular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ac864d0b5a218dbb443a4a510e2990f
https://doi.org/10.1016/j.celrep.2014.05.027
https://doi.org/10.1016/j.celrep.2014.05.027
Autor:
George S. Robertson, J Gillard, Stephen J. Crocker, Martin Holcik, John D. Fisk, Michael Thorne, V. Bhan, Trudy Campbell, Andrea L.O. Hebb, Craig S. Moore, Eric C. LaCasse, Harold A. Robertson
Publikováno v:
Multiple Sclerosis Journal. 14:577-594
A failure of autoreactive T cells to undergo apoptosis may contribute to the pathogenesis of multiple sclerosis (MS). The role of the inhibitor of apoptosis (IAP) family of anti-apoptotic proteins such as X-linked IAP (XIAP), human inhibitor of apopt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ec19ae1473e6f03cd0d67fd2afbe12a
https://doi.org/10.1177/1352458507087468
https://doi.org/10.1177/1352458507087468
Publikováno v:
Brain Research. 1088:176-186
Huntington's disease (HD) is an inherited, progressive neurodegenerative disorder caused by CAG repeat expansion in the gene that codes for the protein huntingtin. The underlying neuropathological events leading to the selectivity of striatal neurona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::694f494ef9173a770107855b52dbd199
https://doi.org/10.1016/j.brainres.2006.02.102
https://doi.org/10.1016/j.brainres.2006.02.102
Autor:
Harold A. Robertson, J.M. Van Kampen
Publikováno v:
Neuroscience. 136:381-386
Small molecule neurotransmitters, such as dopamine, have been shown to regulate cell cycles in the developing brain [ Spencer GE, Klumperman J, Syed NI (1998) Neurotransmitters and neurodevelopment: Role of dopamine in neurite outgrowth, target selec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c12a3c606414690f0681f18bbcc59d67
https://doi.org/10.1016/j.neuroscience.2005.07.054
https://doi.org/10.1016/j.neuroscience.2005.07.054